Atlas Venture Fund XI, L.P.'s Net Worth
Estimate Recalculated Jun 18, 2025 08:57PM EST
Who is Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. has an estimated net worth of $314 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Akero Therapeutics, Inc., Ikena Oncology, Inc., Xilio Therapeutics, Inc., Third Harmonic Bio, Inc., and Korro Bio, Inc..
SEC CIK
Atlas Venture Fund XI, L.P.'s CIK is 0001708269
Past Insider Trading and Trends
2022 was Atlas Venture Fund XI, L.P.'s most active year for acquiring shares with 3 total transactions. Atlas Venture Fund XI, L.P.'s most active month to acquire stocks was the month of August. 2024 was Atlas Venture Fund XI, L.P.'s most active year for disposing of shares, totalling 18 transactions. Atlas Venture Fund XI, L.P.'s most active month to dispose stocks was the month of January. 2022 saw Atlas Venture Fund XI, L.P. paying a total of $5,100,000.00 for 7,366,470 shares, this is the most they've acquired in one year. In 2024 Atlas Venture Fund XI, L.P. cashed out on 1,631,865 shares for a total of $38,262,281.14, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
